Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
NMTC
#3606
NeuroOne Medical Technologies Corporation Common Stock
0.6
7
-2.90%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-2.90%
Monthly Change
-26.37%
6 month change
-8.22%
Year Change
-40.71%
Previous Close
0.6
9
Open
0.6
7
Bid
Ask
Low
0.6
7
High
0.6
7
Volume
7
Markets
US Stock Market
Healthcare
NMTC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Key stats
Total common shares outstanding
30.81 M
30.84 M
30.86 M
49.82 M
50 M
50.41 M
50.53 M
—
Valuation ratios
Enterprise value
25.73 M
29.07 M
24.36 M
41.03 M
25.87 M
38.23 M
34.74 M
139.87 M
Price to earnings ratio
-1.85
-2.15
-3.18
-3.7
-3.99
-9.87
-3.79
-21.35
Price to sales ratio
5.25
7.67
4.06
4.41
3.47
3.92
3.69
15.49
Price to cash flow ratio
-1.78
-2.41
-3.04
-4.56
-5.43
-12.58
-5.75
-28.32
Price to book ratio
1.11
32.23
2.08
3.05
2.05
5.04
1.49
11.64
Enterprise value to EBITDA ratio
-2.15
-2.52
-2.64
-4.56
-3.21
-5.66
-4.74
-18.18
Profitability ratios
Return on assets %
-0.56
-0.62
0.27
-0.51
-0.14
-0.15
-0.17
-0.97
Return on equity %
-0.92
-4.08
0.61
-2.02
-0.18
-0.23
-0.22
-2.65
Return on invested capital %
-739.75
-683.19
249.54
-413.7
-541.53
-334.79
-242.17
-1 532.19
Gross margin %
34.13
51.81
58.85
55.61
53.94
55.77
54.2
219.52
Operating margin %
-338.34
-1 034.48
52.26
-193.29
-111.23
-50.02
-59.02
-413.57
EBITDA margin %
-330.69
-967.57
-31.32
-187.75
-106.32
-46.87
-56.56
-397.51
Net margin %
-335.14
-1 230.55
54.53
-163.76
-88.49
-59.08
-49.71
-361.04
Liquidity ratios
Quick ratio
1.36
0.9
2.41
1.09
5.8
3.47
5.09
15.45
Current ratio
2.42
2.09
3.64
2.13
7.13
4.44
6.41
20.11
Inventory turnover
—
—
0
0
0
0
0
0.01
Asset turnover
0.16
0.05
0.55
0.25
0.22
0.25
0.3
1.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.09
-0.1
0.01
-0
-0.04
-0.04
-0.06
-0.14
EBIT per share
-0.1
-0.11
-0.04
-0.09
-0.05
-0.03
-0.03
-0.21
EBITDA per share
-0.1
-0.1
-0.03
-0.08
-0.05
-0.03
-0.03
-0.2
Total debt per share
—
—
—
—
—
—
—
—
Cash per share
0.06
0.05
0.04
0.04
0.22
0.16
0.07
0.49
Net current asset value per share
0.15
0.17
0.18
0.12
0.28
0.25
0.16
0.81
Tangible book value per share
0.11
0.03
0.09
0.03
0.22
0.18
0.13
0.56
Working capital per share
0.09
0.09
0.13
0.06
0.24
0.2
0.14
0.63
Book value per share
0.11
0.03
0.1
0.04
0.22
0.18
0.13
0.56
News
Best Momentum Stocks to Buy for January 6th
New Strong Buy Stocks for January 6th
NeuroOne、Penumbraの幹部ジェイソン・ミルズを取締役に任命
NeuroOne appoints Penumbra executive Jason Mills to board
【決算速報】Neuroone Medical、売上高は予想を上回り、利益は予想を上回る結果に
Neuroone Medical earnings beat, revenue topped estimates
ニューロワン、2025年第4四半期に収益急増、株価上昇
Earnings call transcript: NeuroOne Q4 2025 sees revenue surge, stock rises
NeuroOne Medical Technologies、Nasdaqの最低入札価格適合に関する延長を取得
NeuroOne Medical Technologies receives Nasdaq extension to regain minimum bid price compliance
NeuroOne社、Nasdaq上場維持のため180日間の延長を獲得
NeuroOne receives 180-day extension to regain nasdaq compliance